The latest Cancer Progress Report reveals a 33% decline in U.S. cancer deaths since 1991, but also highlights the ...
Patients who are overweight when they're first diagnosed with cancer may be at higher risk of developing a second cancer.
Health care system officials said dV5 will help physicians improve surgical outcomes and efficiency by providing enhanced ...
At ESMO Congress 2024, Shuji Ogino, MD, PhD, MS, explained that the rising incidence of young-onset cancer may be due to ...
I moved to Buffalo last summer from Alberta, Canada, to begin medical residency at the University at Buffalo in the MedPeds ...
The newest medical office building in the area is at 1530 Eighth Avenue and opened at the beginning of September.
Verywell Health on MSN10d
Ulcerative Colitis Medication Options: A Pharmacist ExplainsLearn about options for managing the inflammatory bowel disease ulcerative colitis, including prescription medications, ...
Entrectinib is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Metastatic Pancreatic Cancer.
Trabedersen is under clinical development by Sapu Bioscience and currently in Phase III for Pancreatic Ductal Adenocarcinoma.
The US Attorney’s Office, District of Maryland, alleges the company encouraged physicians to incorrectly bill Medicare and Medicaid programs for use of its hemorrhoid removal system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback